A Systematic Critical Appraisal of Clinical Practice Guidelines in Heart Failure Using the AGREE II Tool

Andrew Sephien1, Denisse Camille Dayto2, Tea Reljic3

  • 1Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham, Alabama.

Insights

This systematic review critically appraised heart failure clinical practice guidelines (CPGs) using AGREE II. While clarity and scope were high, applicability and rigor require improvement for better patient care.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines
  • Health Services Research

Background:

  • Multiple clinical practice guidelines (CPGs) exist for heart failure management to optimize patient outcomes.
  • A critical appraisal of the methodological quality of these heart failure guidelines has been lacking.

Approach:

  • A systematic review was conducted to assess the methodological quality of heart failure CPGs published between January 1, 2021, and September 8, 2022.
  • The Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument was used to evaluate 6 included CPGs.
  • CPGs were sourced from North America, Asia, Europe, and South America.

Key Points:

  • Median AGREE II scores varied significantly across domains: 100% for Scope and Purpose, Clarity of Presentation, and Editorial Independence.
  • Scores for Stakeholder Involvement and Rigor of Development were 71%, while Applicability scored 43%.
  • Overall assessment scores averaged 64%.

Conclusions:

  • Current heart failure CPGs demonstrate high quality in scope, clarity, and independence but show variability in stakeholder involvement, rigor, and applicability.
  • Standardized approaches and the AGREE II tool can enhance the methodological rigor, reporting, and practical application of future CPGs.
  • Improvements are needed to ensure CPGs effectively translate to improved patient morbidity and mortality in heart failure management.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
99
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14